Delivery Order SPE2DB25D3012-SPE2DB25FWZMD
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.40 on August 5, 2025, for the supply of Veklury 100 mg vials, an antiviral medication used in treating severe respiratory infections. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $15,848.80 and a firm fixed price contract structure. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $3,404.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of VEKLURY 100 mg vials, with a performance period through March 26, 2024. The contract is a firm fixed-price award and does not have a set-aside designation. Amerisourcebergen Drug Corp serves as...
- This delivery order, awarded August 25, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Veklury 100 mg vials with a ceiling value of $2,377.32. The contract utilizes firm fixed pricing with an ultimate completion date of September 16, 2025, and is classified as a child contract under a larger indefinite delivery vehicle. The award was made through open competition with no set-aside designation, and performance will occur at the vendor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $7,924.40. This firm fixed-price delivery order, which is a child contract under a larger vehicle, is scheduled for completion by September 11, 2025, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation,...
- This is a $4,085.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VEKLURY 100 MG VIALS. The contract has a completion date of September 5, 2024 and was awarded on August 14, 2024. This order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,618.40 contract is for the supply of 100 mg vials of the drug Veklury with a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 2025, which serves...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of VEKLURY 100 MG Vials, a pharmaceutical product, with a firm fixed price of $3,404.60 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,427.60 firm fixed-price delivery order is for the supply of VEKLURY 100 mg vials, a pharmaceutical product used to treat COVID-19. The contract has an ultimate completion date of August 2, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $13,606.80 by the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 mg vials of Veklury. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with all supplies delivered by December 27, 2023. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract held by Amerisourcebergen with DLA Troop...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZMDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, valued at $7,924.40 under a firm fixed price contract type. This competitively awarded, non-set-aside delivery order has an ultimate completion date of September 16, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order represents a child contract action under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC provides a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contractor's established portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 8/25/25 |